Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 3, 1997, Pages 274-283

  Pichler, C E ^a   Marquardsen, A ^c   Sparholt, S ^c   Lowenstein H ^c   Bircher, A ^b   Bischof, M ^a   Pichler, W J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c ALK ABELLÓ   (Denmark)

Author keywords

Bronchial hyperreactivity; House dust mite allergy; Specific immunotherapy

Indexed keywords

ALLERGEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TEST;

EID: 0031001693     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb00991.x     Document Type: Article

References (46)

1. Platts-Mills TAE, de Weck AL. Dust mite allergens and asthma - a worldwide problem. J Allergy Clin Immunol 1989;83:416-27.
2. Platts-Mills TAE, Thomas WR, Aalberse RC, Vervloet D, Chapman MD. Dust mite allergens and asthma: report of a second international workshop. J Allergy Clin Immunol 1992;89:1046-60.
3. Platts-Mills TAE, Michel EB, Nock P, Tovey ER, Moszoro H, Wilkins SR. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982;2:675-8.
4. Charpin D, Birnbaum J, Haddi E, et al. Altitude and allergy to house dust mites: a paradigm of the influence of environmental exposure on allergic sensitization. Am Rev Respir Dis 1991;143:983-6.
5. Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn U. Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol 1992;90:125-38.
6. Bousquet J, Hejjaoui A, Michel F-B. Specific immunotherapy in asthma. J Allergy Clin Immunol 1990;86:292-305.
7. Royal College of Physicians and Royal College of Pathologists. Good allergy practice - standards of care providers and purchasers of allergy services within the National Health Service. Clin Exp Allergy 1995;25:586-95.
8. Malling H-J, Weeke B. Immunotherapy. Position paper. Allergy 1993;48 Suppl 14:9-35.
9. Aas K. Hyposensitization in house dust allergy asthma: a double-blind controlled study with evaluation of the effect on bronchial sensitivity to house dust. Acta Paediatr Scand 1971;60:264-8.
10. Warner JO, Price JF, Soothill JF, et al. Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978;2:912-15.
11. Rak S, Löwhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen allergic patients. Allergy Clin Immunol 1988;82:470-80.
12. Bousquet J, Hejjaoui A, Clauzel A-M, et al. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:971-7.
13. Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 1993;91:709-22.
14. Haugaard L, Dahl R. Immunotherapy in patients allergic to cat and dog dander. Allergy 1992;47:249-54.
15. Bucur J, Dreborg S, Einarsson R, Ljungstedt-Påhlman I, Nilsson JE, Persson G. Immunotherapy with dog and cat allergen in dog-sensitive and cat-sensitive asthmatics. Ann Allergy 1989;62:355-61.
16. van Metre TE, Marsh DG, Adkinson FN, et al. Immunotherapy for cat asthma. Allergy Clin Immunol 1988;82: 1055-68.
17. Sundin B, Lilja G, Graff-Lonnevig V, et al. Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double blind study on patients with animal dander extracts. J Allergy Clin Immunol 1986;77:478-87.
18. Taylor WW, Ohman JL, Lowell TC. Immunotherapy in cat induced asthma. Double blind trial with evaluation of bronchial responses to cat allergen and histamine. J Allergy Clin Immunol 1978;61:283-7.
19. Mosbech H, Dreborg S, Frølund L, et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract. II. Effect evaluated by challenges with allergen and histamine. Allergy 1989;44:499-509.
20. Østerballe O, Weeke B. A new lancet for skin prick testing. Allergy 1979;34:209-12.
21. Gronemeyer U. Der konjunktivale Provokationstest. In: Schulz KH, Fuchs E, editors. Manuale allergologicum. Vol. IV. Deisenhofen: Dustri, 1988:6.
22. Roisman GL, Pfeiffer C, Lacronique JG, Le Cae A, Dusser DJ. Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment. J Clin Invest 1995;96(1):12-21.
23. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-43.
24. Pavlovic M, Holstein-Rathlou NH, Madsen F, Gerner Svendsen U, Weeke B. Bronchial histamine challenge. A combined interrupter-dosimeter method compared with a standard method. Allergy 1985;40:574-9.
25. Beach JR, Young CL, Avery AJ, et al. Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response. Thorax 1993;48:239-43.
26. Johansen N, Heinig JH, Mosbech H. A new equipment for standardized dust sampling [Abstract]. XVII Nordic Congress of Allergology, Aarhus, 1990.
27. Lind P. Enzyme-linked immunosorbent assay for determination of major excrement allergens of house dust mite species D. pteronyssinus, D. farinae and D. microceras. Allergy 1986;41:442-51.
28. 20 determination in a random selection of young college students. J Allergy Clin Immunol 1992;89:23-30.
29. Ortolani C, Pastorello E, Moss RB, et al. Grass-pollen immunotherapy: a single year, double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J Allergy Clin Immunol 1984;73:283-90.
30. Löfkvist T, Agrell B, Dreborg S, Svensson G. Effects of immunotherapy with a purified standardized allergen preparation of Dermatophagoides farinae in adults with perennial allergic rhinoconjunctivitis. Allergy 1994;49:100-7.
31. Mosbech H, Djurup R, Dreborg S, Kaegaard Poulsen L, Stahl Skov P, Steringer I. Hyposensitization in asthmatics with mPEG-modified and unmodified house dust mite extract. III. Effect on mite-specific immunological parameters and correlation to changes in mite-sensitivity and symptoms. Allergy 1990;45:130-41.
32. van der Heide S, de Monchy JGR, de Vries K, Bruggink TM, Kauffmann HF. Seasonal variation in airway hyperresponsiveness and natural exposure to house dust mite allergens in patients with asthma. J Allergy Clin Immunol 1994;93:470-5.
33. Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 1977;7:503-13.
34. Cartier A, Thomson NC, Frith PA, Roberts R, Hargreave FE. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airways caliber. J Allergy Clin Immunol 1982;70:170-7.
35. Woolcock AJ, Yan K, Salome CM. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin Allergy 1988;18:165-76.
36. Broder I, Tarlo SM, Davies GM, et al. Safety and efficacy of long term treatment with inhaled beclomethasone dipropionate in steroid-dependent asthma. Can Med Assoc J 1987;136:124-9.
37. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131:599-606.
38. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154: 4187-94.
39. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123.
40. Clough JB, Holgate ST. The natural history of bronchial hyperresponsiveness. Clin Rev Allergy 1989;7:257-78.
41. Postma DS, Bleecker ER, Amelung PJ, et al. Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995;333:894-900.
42. Marsh DG, Neely JD, Breazeale DR, et al. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-6.
43. Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, Holdaway MD. Relation between airway responsiveness and serum IgE in children with asthma and in appar-ently normal children. N Engl J Med 1992;325: 1067-71.
44. Crivelli M, Zeller C, Bachofen H. Spektrum der bronchialen Reaktion auf Carbachol-Inhalationen bei Patienten mit Verdachtsdiagnose asthmatischer Husten. Schweiz Med Wochenschr 1985;115:620-4.
45. Chung KF. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 1986;41:657-62.
46. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013-26.